GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Quick Ratio

Caplin Point Laboratories (BOM:524742) Quick Ratio : 4.63 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Caplin Point Laboratories's quick ratio for the quarter that ended in Mar. 2024 was 4.63.

Caplin Point Laboratories has a quick ratio of 4.63. It generally indicates good short-term financial strength.

The historical rank and industry rank for Caplin Point Laboratories's Quick Ratio or its related term are showing as below:

BOM:524742' s Quick Ratio Range Over the Past 10 Years
Min: 0.36   Med: 4.05   Max: 5.85
Current: 4.63

During the past 13 years, Caplin Point Laboratories's highest Quick Ratio was 5.85. The lowest was 0.36. And the median was 4.05.

BOM:524742's Quick Ratio is ranked better than
87.96% of 1071 companies
in the Drug Manufacturers industry
Industry Median: 1.33 vs BOM:524742: 4.63

Caplin Point Laboratories Quick Ratio Historical Data

The historical data trend for Caplin Point Laboratories's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Quick Ratio Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.05 5.85 5.15 4.72 4.63

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.72 - 4.53 - 4.63

Competitive Comparison of Caplin Point Laboratories's Quick Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Quick Ratio falls into.



Caplin Point Laboratories Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Caplin Point Laboratories's Quick Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Quick Ratio (A: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(18922.1-3630.4)/3305.6
=4.63

Caplin Point Laboratories's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(18922.1-3630.4)/3305.6
=4.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories  (BOM:524742) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Caplin Point Laboratories Quick Ratio Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines